In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction.
Main Authors: | Sandra Silva-Arrieta, Philip J R Goulder, Christian Brander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-06-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1008607 |
Similar Items
-
In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
by: Mahmoud M. Shehata, et al.
Published: (2021-10-01) -
In-silico design of a new multi-epitope vaccine candidate against SARS-CoV-2
by: Abbas Alibakhshi, et al.
Published: (2024-01-01) -
In Silico Design of a Multivalent Epitope Vaccine Against SARS-CoV-2 for Iranian Populations
by: Faezeh Soltanveis, et al.
Published: (2021-11-01) -
Landscape and selection of vaccine epitopes in SARS-CoV-2
by: Christof C. Smith, et al.
Published: (2021-06-01) -
Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
by: Yazdani Z, et al.
Published: (2020-08-01)